Sohm Inc.
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in … Read more
Sohm Inc. (SHMN) - Net Assets
Latest net assets as of March 2025: $-141.07K USD
Based on the latest financial reports, Sohm Inc. (SHMN) has net assets worth $-141.07K USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.91 Million) and total liabilities ($5.05 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-141.07K |
| % of Total Assets | -2.88% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Sohm Inc. - Net Assets Trend (2009–2024)
This chart illustrates how Sohm Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Sohm Inc. (2009–2024)
The table below shows the annual net assets of Sohm Inc. from 2009 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-93.83K | +74.68% |
| 2023-12-31 | $-370.51K | +62.90% |
| 2022-12-31 | $-998.62K | +8.48% |
| 2021-12-31 | $-1.09 Million | +7.48% |
| 2020-12-31 | $-1.18 Million | +2.73% |
| 2019-12-31 | $-1.21 Million | +3.43% |
| 2018-12-31 | $-1.26 Million | +3.30% |
| 2017-12-31 | $-1.30 Million | -5.20% |
| 2016-12-31 | $-1.23 Million | -37.40% |
| 2015-12-31 | $-898.43K | +48.01% |
| 2013-12-31 | $-1.73 Million | -145.50% |
| 2012-12-31 | $-703.95K | -259.13% |
| 2011-12-31 | $442.38K | +1971.86% |
| 2010-12-31 | $-23.63K | +88.86% |
| 2009-12-31 | $-212.15K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sohm Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 124620700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.37 Million | % |
| Other Components | $885.00K | % |
| Total Equity | $-93.83K | 100.00% |
Sohm Inc. Competitors by Market Cap
The table below lists competitors of Sohm Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Green Star Products
PINK:GSPI
|
$6.57 |
|
Intl Star Inc
PINK:ILST
|
$6.59 |
|
Wireless Xcessories Group Inc
PINK:WIRX
|
$6.61 |
|
Wanderport Corp
PINK:WDRP
|
$6.66 |
|
Terax Energy Inc
PINK:TEXG
|
$6.44 |
|
Mundus Group Inc
PINK:MNDP
|
$6.30 |
|
Digital 9 Infrastructure PLC
LSE:DGI9
|
$6.18 |
|
Aquis Exchange PLC
LSE:AQX
|
$6.15 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sohm Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -370,514 to -93,825, a change of 276,689.
- Net loss of 607,893 reduced equity.
- Other factors increased equity by 884,582.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-607.89K | -647.9% |
| Other Changes | $884.58K | +942.8% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Sohm Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $0.00 | $0.00 | x |
| 2016-12-31 | $0.00 | $0.00 | x |
| 2017-12-31 | $0.00 | $0.00 | x |
| 2018-12-31 | $0.00 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
| 2024-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sohm Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -64.05%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-9.80%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 0.00% | -291.03% | 0.51x | 0.00x | $-546.02K |
| 2010 | 0.00% | -125.43% | 1.15x | 0.00x | $-978.09K |
| 2011 | -124.10% | -40.96% | 0.53x | 5.72x | $-593.23K |
| 2012 | 0.00% | -87.26% | 0.41x | 0.00x | $-1.06 Million |
| 2013 | 0.00% | -52.26% | 0.67x | 0.00x | $-851.46K |
| 2015 | -14.12% | -229.07% | 0.06x | 1.00x | $-1.09 Million |
| 2016 | -8.76% | -17.56% | 0.50x | 1.00x | $-46.72K |
| 2017 | 0.00% | -36.87% | 1.11x | 0.00x | $65.72K |
| 2018 | 0.00% | 12.33% | 2.97x | 0.00x | $177.72K |
| 2019 | 0.00% | 26.48% | 1.28x | 0.00x | $164.39K |
| 2020 | 0.00% | 14.08% | 1.56x | 0.00x | $151.04K |
| 2021 | 0.00% | 27.17% | 1.98x | 0.00x | $197.40K |
| 2022 | 0.00% | 26.67% | 1.17x | 0.00x | $192.44K |
| 2023 | 0.00% | -73.74% | 0.27x | 0.00x | $-259.85K |
| 2024 | 0.00% | -64.05% | 0.20x | 0.00x | $-598.51K |
Industry Comparison
This section compares Sohm Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sohm Inc. (SHMN) | $-141.07K | 0.00% | N/A | $6.56 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |